Keywords: centocor, extends, license, morphosys, antibody, usa-based, subsidiary
Centocor extends license to MorphoSys' antibody
Article | 30 August 2004
USA-based Centocor, a subsidiary of drug major Johnson & Johnson, hasexercised its right to retain a commercial license to MorphoSys AG's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
